- Last sale
- Nov 12, 2026 · -4.09%
- Market cap
- $7.22M
- 51.36M shares
- Filings
- 185
FY 2025+19.8% FY25 yoy
FY 2025N/M FY25 yoy
FY 2025N/M FY25 yoy
FY 2025derivedN/M FY25 yoy
FY 2025N/M FY25 yoy
FY 2025−38.0% FY25 yoy
- $7.22M
- —
- 0.1×
- —
- -46.33%
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $107,875,000 | reported | |
| FY 2024 | 2024-12-31 | $90,049,000 | reported | |
| FY 2023 | 2023-12-31 | $70,193,000 | reported | |
| FY 2022 | 2022-12-31 | $37,054,000 | reported | |
| FY 2021 | 2021-12-31 | $22,239,000 | reported | |
| FY 2020 | 2020-12-31 | $18,460,000 | reported | |
| FY 2019 | 2019-12-31 | $11,785,000 | reported |
Segments
Products
LineFY2025ShareChange
Tissue-based revenue$81.49M76%+12.7%
Liquid-based revenue$26.06M24%+48.2%
Royalties and other revenues$326.00K0.3%+134.5%
Total$107.88M
Medical laboratories
MDxHealth SA is the 14th largest of the 29 covered companies the SEC files under this code, by revenue. SIC 8071
CompanyRevenueGrowthNet marginMarket cap
CSTLCastle Biosciences Inc$344.2M3.7%7.0%$1.1BFLGTFulgent Genetics, Inc.$322.7M13.8%18.8%$693.9MBLLNBillionToOne, Inc.$305.1M100.0%2.4%$5.3BGRALGrail, Inc.$147.2M17.2%277.5%$5.5B
MDXHMDxHealth SA (this company)$107.9M19.8%31.1%$7.2M
BDSXBiodesix Inc$88.5M24.1%39.8%$108.8MBNRBurning Rock Biotech Ltd$77.2M9.2%10.3%$151.0MPSNLPersonalis, Inc.$69.6M17.7%116.7%$1.7BXGNExagen Inc.$66.6M19.7%30.0%$194.0MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
MDxHealth SA · CIK 1872529 · Engraved from SEC EDGAR